CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 86 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $902,147 | -79.0% | 41,326 | -69.4% | 0.00% | -100.0% |
| Q2 2023 | $4,297,691 | +310.2% | 135,190 | +214.7% | 0.00% | – |
| Q1 2023 | $1,047,696 | +248.9% | 42,956 | +351.2% | 0.00% | – |
| Q4 2022 | $300,292 | -88.0% | 9,521 | -86.7% | 0.00% | – |
| Q1 2022 | $2,511,000 | -29.7% | 71,734 | -34.9% | 0.00% | -100.0% |
| Q4 2021 | $3,573,000 | -14.1% | 110,219 | -21.9% | 0.00% | 0.0% |
| Q3 2021 | $4,161,000 | +190.0% | 141,062 | +151.9% | 0.00% | 0.0% |
| Q2 2021 | $1,435,000 | – | 55,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |